Search results
Novartis lifts FY guidance after Q1 results beat expectations
WSAU Wausau· 1 day agoBy Ludwig Burger FRANKFURT (Reuters) -Swiss drugmaker Novartis on Tuesday raised its full-year...
Novartis (NVS) to Report Q1 Earnings: What to Expect?
Zacks· 5 days agoNVS’ first-quarter sales are likely to have been boosted by Kesimpta, Entresto, Kisqali and Pluvicto. Cardiovascular drug Entresto sales witnessed a solid year-over-year surge ...
UPDATE 4-Novartis raises guidance after beating Q1 expectations
Reuters via Yahoo Finance· 1 day agoSwiss drugmaker Novartis raised its full-year guidance on wider use of psoriasis and arthritis drug Cosentyx on Tuesday and said it had tapped the former boss of Bristol Myers Squibb (BMS) to ...
The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and...
Zacks· 1 day agoApril 23, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the ...